Literature DB >> 24055887

Ceramide signaling in mammalian epidermis.

Yoshikazu Uchida1.   

Abstract

Ceramide, the backbone structure of all sphingolipids, as well as a minor component of cellular membranes, has a unique role in the skin, by forming the epidermal permeability barrier at the extracellular domains of the outermost layer of the skin, the stratum corneum, which is required for terrestrial mammalian survival. In contrast to the role of ceramide in forming the permeability barrier, the signaling roles of ceramide and its metabolites have not yet been recognized. Ceramide and/or its metabolites regulate proliferation, differentiation, and apoptosis in epidermal keratinocytes. Recent studies have further demonstrated that a ceramide metabolite, sphingosine-1-phosphate, modulates innate immune function. Ceramide has already been applied to therapeutic approaches for treatment of eczema associated with attenuated epidermal permeability barrier function. Pharmacological modulation of ceramide and its metabolites' signaling can also be applied to cutaneous disease prevention and therapy. The author here describes the signaling roles of ceramide and its metabolites in mammalian cells and tissues, including the epidermis. This article is part of a Special Issue entitled The Important Role of Lipids in the Epidermis and their Role in the Formation and Maintenance of the Cutaneous Barrier. Guest Editors: Kenneth R. Feingold and Peter Elias.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ceramide; Epidermis; Keratinocyte; Signaling; Sphingolipid

Mesh:

Substances:

Year:  2013        PMID: 24055887      PMCID: PMC3943494          DOI: 10.1016/j.bbalip.2013.09.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  153 in total

1.  Purification of rat brain membrane neutral sphingomyelinase.

Authors:  B Liu; Y A Hannun
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

Review 2.  Ceramidases in the regulation of ceramide levels and function.

Authors:  Samer el Bawab; Cungui Mao; Lina M Obeid; Yasuf A Hannun
Journal:  Subcell Biochem       Date:  2002

3.  Glucosylceramide synthesis and synthase expression protect against ceramide-induced stress.

Authors:  Yoshikazu Uchida; Satoru Murata; Matthias Schmuth; Martin J Behne; Jeong Deuk Lee; Shinichi Ichikawa; Peter M Elias; Yoshio Hirabayashi; Walter M Holleran
Journal:  J Lipid Res       Date:  2002-08       Impact factor: 5.922

4.  Molecular cloning and expression of mouse ceramide glucosyltransferase.

Authors:  S Ichikawa; K Ozawa; Y Hirabayashi
Journal:  Biochem Mol Biol Int       Date:  1998-05

5.  Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release.

Authors:  Benjamin J Pettus; Alicja Bielawska; Sarah Spiegel; Patrick Roddy; Yusuf A Hannun; Charles E Chalfant
Journal:  J Biol Chem       Date:  2003-07-10       Impact factor: 5.157

6.  The formation of ceramide-1-phosphate during neutrophil phagocytosis and its role in liposome fusion.

Authors:  V T Hinkovska-Galcheva; L A Boxer; P J Mansfield; D Harsh; A Blackwood; J A Shayman
Journal:  J Biol Chem       Date:  1998-12-11       Impact factor: 5.157

7.  Analysis and quantitation of free ceramide containing nonhydroxy and 2-hydroxy fatty acids, and phytosphingosine by high-performance liquid chromatography.

Authors:  M Iwamori; C Costello; H W Moser
Journal:  J Lipid Res       Date:  1979-01       Impact factor: 5.922

8.  Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling.

Authors:  Anthony Ambesi; Paula J McKeown-Longo
Journal:  Mol Cancer Res       Date:  2009-02-10       Impact factor: 5.852

9.  Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network.

Authors:  Masayuki Nagahashi; Eugene Y Kim; Akimitsu Yamada; Subramaniam Ramachandran; Jeremy C Allegood; Nitai C Hait; Michael Maceyka; Sheldon Milstien; Kazuaki Takabe; Sarah Spiegel
Journal:  FASEB J       Date:  2012-11-24       Impact factor: 5.191

10.  Ganglioside GT1b inhibits keratinocyte adhesion and migration on a fibronectin matrix.

Authors:  A S Paller; S L Arnsmeier; J D Chen; D T Woodley
Journal:  J Invest Dermatol       Date:  1995-08       Impact factor: 8.551

View more
  31 in total

1.  The 5XFAD Mouse Model of Alzheimer's Disease Exhibits an Age-Dependent Increase in Anti-Ceramide IgG and Exogenous Administration of Ceramide Further Increases Anti-Ceramide Titers and Amyloid Plaque Burden.

Authors:  Michael B Dinkins; Somsankar Dasgupta; Guanghu Wang; Gu Zhu; Qian He; Ji Na Kong; Erhard Bieberich
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Distribution of bioactive lipid mediators in human skin.

Authors:  Alexandra C Kendall; Suzanne M Pilkington; Karen A Massey; Gary Sassano; Lesley E Rhodes; Anna Nicolaou
Journal:  J Invest Dermatol       Date:  2015-02-10       Impact factor: 8.551

3.  An endoplasmic reticulum stress-initiated sphingolipid metabolite, ceramide-1-phosphate, regulates epithelial innate immunity by stimulating β-defensin production.

Authors:  Young-Il Kim; Kyungho Park; Jong Youl Kim; Ho Seong Seo; Kyong-Oh Shin; Yong-Moon Lee; Walter M Holleran; Peter M Elias; Yoshikazu Uchida
Journal:  Mol Cell Biol       Date:  2014-10-13       Impact factor: 4.272

4.  Ceramide-C16 Is a Versatile Modulator of Phosphatidylethanolamine Polymorphism.

Authors:  Mahmoudreza Doroudgar; Michel Lafleur
Journal:  Biophys J       Date:  2017-06-06       Impact factor: 4.033

5.  Sphingosine kinase 1 activation enhances epidermal innate immunity through sphingosine-1-phosphate stimulation of cathelicidin production.

Authors:  Se Kyoo Jeong; Young Il Kim; Kyong-Oh Shin; Bong-Woo Kim; Sin Hee Lee; Jeong Eun Jeon; Hyun Jong Kim; Yong-Moon Lee; Theodora M Mauro; Peter M Elias; Yoshikazu Uchida; Kyungho Park
Journal:  J Dermatol Sci       Date:  2015-06-19       Impact factor: 4.563

6.  Mutations in KDSR Cause Recessive Progressive Symmetric Erythrokeratoderma.

Authors:  Lynn M Boyden; Nicholas G Vincent; Jing Zhou; Ronghua Hu; Brittany G Craiglow; Susan J Bayliss; Ilana S Rosman; Anne W Lucky; Luis A Diaz; Lowell A Goldsmith; Amy S Paller; Richard P Lifton; Susan J Baserga; Keith A Choate
Journal:  Am J Hum Genet       Date:  2017-06-01       Impact factor: 11.025

7.  Short Term Palmitate Supply Impairs Intestinal Insulin Signaling via Ceramide Production.

Authors:  Thi Thu Trang Tran; Bárbara Graziela Postal; Sylvie Demignot; Agnès Ribeiro; Céline Osinski; Jean-Paul Pais de Barros; Agnieszka Blachnio-Zabielska; Armelle Leturque; Monique Rousset; Pascal Ferré; Eric Hajduch; Véronique Carrière
Journal:  J Biol Chem       Date:  2016-06-02       Impact factor: 5.157

8.  [Pathogenic and Compensatory Mechanisms in Epidermis of Sphingomyelin Synthase 2-Deficient Mice].

Authors:  Shota Sakai; Asami Makino; Akihito Nishi; Takeshi Ichikawa; Tadashi Yamashita; Makoto Taniguchi; Yoshihiro Tokudome; Yoshio Hirabayashi; Masashi Akiyama; Debra Crumrine; Yoshikazu Uchida; Peter M Elias; Tetsuya Tsuchida; Sumiko Hamanaka
Journal:  Skin Pharmacol Physiol       Date:  2021-04-29       Impact factor: 3.479

Review 9.  Ceramides in Skin Health and Disease: An Update.

Authors:  Yoshikazu Uchida; Kyungho Park
Journal:  Am J Clin Dermatol       Date:  2021-07-20       Impact factor: 7.403

10.  Progressive symmetrical erythrokeratoderma manifesting as harlequin-like ichthyosis with severe thrombocytopenia secondary to a homozygous 3-ketodihydrosphingosine reductase mutation.

Authors:  Lama Altawil; Hind Alshihry; Huda Alfaraidi; Amal Alhashem; Ahmed Alhumidi; Fowzan S Alkuraya
Journal:  JAAD Case Rep       Date:  2021-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.